Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple home treatments may boost leg strength after amputation

NCT ID NCT07664995

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests two non-invasive treatments—ischemic conditioning (using a blood pressure cuff to briefly restrict blood flow) and neuromuscular electrical stimulation (mild electrical pulses to trigger muscle contractions)—in 24 adults with above- or below-knee amputation. Participants will do one or both treatments at home every other day for two weeks. Researchers will measure changes in walking speed, muscle strength, and movement patterns to see if these therapies can improve function and mobility.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ischemic conditioning (blood pressure cuff) and neuromuscular electrical stimulation
What this could lead to
If it works, this could point toward a simple home-based therapy to improve walking and muscle strength after leg amputation.
What could go wrong
This is a very small early trial (24 people) with no placebo group, so results may not apply widely. The interventions are short-term (2 weeks) and may not produce lasting benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 24 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Older than 18 years old * History of unilateral transfemoral or transtibial amputation * Able to ambulate independently without the use of aids (i.e., walking cane) * Able to walk at least 6 minutes continuously without stopping. * Has a safe residuum with no open wounds on either the residual or intact limb * Has a prosthetic limb with materials that are sound and safe to withstand the mobility requirements of the study Exclusion Criteria: * Younger than 18 years old * Inability to give informed consent * Neurological disorder such as multiple sclerosis that affects gait * Currently pregnant (or intend to become pregnant while participating in study) * Blood clots in the leg, or any condition in which compression of the thigh or transient ischemia is contraindicated (e.g. open wounds in the leg) * History of uncontrolled hypertension * History of heart failure * Implanted electrical device such as a pacemaker or defibrillator * Head injury within the previous 6 months * Seizure disorder * History of thrombosis * History of sickle cell trait * History of genetic disease that impacts gait (e.g. cerebral palsy, muscular dystrophy).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Below knee amputation are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • University of Illinois Chicago

    Chicago, Illinois, 60607, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.